Stroke
Conditions
Interventions
EECP plus IMT Group (Combined Group):Conventional stroke medication, respiratory training, and limb function rehabilitation + IMT (POWERbreathe K5 inspiratory muscle trainer, intensity 30%-50% MIP) +
once daily, 5 times per week for 4 weeks
IMT Group:Conventional stroke medication, respiratory training, and limb function rehabilitation + IMT (POWERbreathe K5 inspiratory muscle trainer, intensity 30%-50% MIP)
Control Group:Conventional stroke medication, respiratory training, and limb function rehabilitation
Sponsors
Beijing Xiaotangshan Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The patient's diagnosis meets the criteria for stroke. The results of head CT or MRI examinations can clearly confirm that the selected subjects are patients with ischemic stroke. The patient must have been diagnosed for the first time and the duration of the disease should be no more than 6 months. 2. Age: 40 - 75 years old. 3. Stable vital signs, without speech or cognitive function disorders. 4. Able to cooperate with the completion of respiratory training. 5. The patient's clinical data is complete and the informed consent form has been signed.
Exclusion criteria
Exclusion criteria: 1. History of lung and thoracic-abdominal diseases; 2. Complicated with myasthenia gravis or diaphragmatic nerve paralysis; 3. Having a history of malignant tumors or serious diseases of important organs such as the heart, liver, and kidneys; 4. The patient has brainstem infarction; 5. There is a cardiac pacemaker or other metal implants in the body; 6. Pregnant or lactating women; 7. Patients with a history of epilepsy; 8. Those whose conditions prevent them from cooperating with treatment for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Six-Minute Walk Test (6MWT);Safety Outcomes (including adverse events, serious adverse events, new lesions, deterioration of existing symptoms or signs, worsening of concomitant diseases, lower limb edema, muscle soreness, bruising, blood pressure fluctuations, etc.); | — |
Secondary
| Measure | Time frame |
|---|---|
| Left Ventricular Ejection Fraction (LVEF);Left Ventricular End-Systolic Diameter (LVESD);Left Ventricular End-Diastolic Diameter (LVEDD);Forced Vital Capacity (FVC);Forced Expiratory Volume in the First Second (FEV1);Maximum Voluntary Ventilation (MVV);Maximal Inspiratory Pressure (MIP);Peak Expiratory Flow (PEF); | — |
Countries
China
Contacts
Public ContactLiu Mingyue
Beijing Xiaotangshan Hospital
Outcome results
None listed